Navigation Links
New compounds may control deadly fungal infections
Date:12/22/2009

An estimated 25,000 Americans develop severe fungal infections each year, leading to 10,000 deaths despite the use of anti-fungal drugs. The associated cost to the U.S. health care system has been estimated at $1 billion a year.

Now two Syracuse University scientists have developed new brominated furanones that exhibit powerful anti-fungal properties.

The most virulent fungus is Candida albicans, which is carried by about 75 percent of the public. Typically the fungus is harmless but, in individuals with HIV or otherwise compromised immune systems, it can cause candidiasis, which has a high mortality rate. The fungi can also form biofilms that attach to surfaces and are up to 1,000 times more resistant to anti-fungals.

"These new furanones have the potential to control such infections and save lives," says assistant professor Dacheng Ren of the Department of Biomedical and Chemical Engineering in SU's L.C. Smith College of Engineering and Computer Science. "In our tests, they reduced fungal growth by more than 80 percent, and we hope to improve on that going forward."

Ren and his collaborator, chemistry professor Yan-Yeung Luk of SU's College of Arts and Sciences, have filed a non-provisional patent application. They have also published related results in the Journal of Applied Microbiology and Biotechnology.

Over the past 20 years, pathogenic fungi have developed growing resistance to anti-fungal drugs. This stimulated a strong demand for more effective drugs and led to the successful research at Syracuse. The researchers' genomic study suggests that furanones have different genetic targets than current anti-fungal agents and thus may avoid drug resistance acquired in the past. The research team has also shown previously that these furanones inhibit bacterial biofilm formation; thus they may help control chronic infections where biofilms often appear, on surgical, dental and other implants.

Ongoing furanones research at Syracuse University will investigate a broad spectrum of other potential capabilities, ranging from diverse medical uses, such as controlling bacterial and fungal biofilms, to anti-fungal wood preservatives for the building materials market.


'/>"/>

Contact: Sara Miler
semortim@syr.edu
315-443-9038
Syracuse University
Source:Eurekalert

Related biology news :

1. Boron-based compounds trick a biomedical protein
2. Natural compounds, chemotherapeutic drugs may become partners in cancer therapy
3. MSU discoveries upend traditional thinking about how plants make certain compounds
4. Compounds could be new class of cancer drugs
5. Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds
6. 2 new compounds show promise for eliminating breast cancer tumors
7. Two new compounds show promise for eliminating breast cancer tumors
8. Scripps research scientists identify compounds for stem-cell production from adult cells
9. 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
10. New $11 million center to speed production of new compounds for drug discovery
11. Discovery of natural compounds that could slow blood vessel growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2017)... -- According to Acuity Market Intelligence, ongoing concerns ... continue to embrace biometric and digital identification based ... Control (ABC) eGates and 1436 Automated Passport Control ... ports of entry across the globe. Deployments increased ... CAGR of 37%. APC Kiosks reached 75% growth ...
(Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
(Date:1/26/2017)... Jan. 26, 2017  Acuity Market Intelligence today ... and Digital Identity".  Acuity characterizes 2017 as a ... increased adoption reflects a new understanding of the ... "Biometrics and digital identity are often perceived as ... Most , Principal of Acuity Market intelligence. "However, ...
Breaking Biology News(10 mins):
(Date:2/15/2017)... , ... February 15, 2017 , ... ... as President and Chief Commercial Officer with GenePeeks. Matt is a veteran ... GenePeeks is a computational genomics company focused on identifying inherited disease risk in ...
(Date:2/15/2017)... Februar 2017  Trianni, Inc. („TRIANNI") gab heute ... eine Lizenzvereinbarung über die Verwendung der The Trianni ... für die Entdeckung monoklonaler Antikörper. Die ... Gensegmentdesign aus, das Janssen den Zugang ... und das für die schelle Isolierung vollständig menschlicher ...
(Date:2/15/2017)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today ... quarter and full year ended December 31, 2016. ... Vanda as we continued to demonstrate strong growth ... for Fanapt," said Mihael H. Polymeropoulos, M.D., Vanda,s ... with important 2017 milestones underscores Vanda,s commitment to ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology: